Ontrak (OTRK)
(Delayed Data from NSDQ)
$0.21 USD
0.00 (1.46%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.20 -0.01 (-4.31%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Ontrak, Inc. [OTRK]
Reports for Purchase
Showing records 1 - 14 ( 14 total )
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
2Q24: Rev Stabilized Should Climb, Signs Up Large NE Regional Health Plan
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid WholeHealth+ Data Underscores Its Financial Benefit
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Comprehensive Healthcare Integration Framework Enhances Care Delivery
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Launches Mental Health Digital Twin Tech For Precision Mental Healthcare
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
1Q24: Revenue Decline From 1Q24 Loss of Large Client Should Reverse In 2H24
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
4Q23: Revenue Impact From Large Client Loss Should Reverse In Short Order
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
We are initiating coverage of OTRK with a Buy rating and a 12-month price target of $4
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
|